Friday, July 25, 2014

What kind of sunglasses should you chose to protect your vision?


Sunglasses can protect your eyes from harmful ultraviolet rays (UV) and high-energy visible light -- light from the blue part of the spectrum, implicated in cataracts and retina damage.

Wrap around protective sunglasses also shield away wind and sunlight that affects people with dry eyes.

Here are some tips when you chose sunglasses.

Claims. Labels for sunglasses are not regulated and are often inconsistent and confusing. A sticker that says "blocks UV" or "UV-absorbent" is meaningless because it doesn't tell you how much UV is blocked. Sunglasses with stickers that claim to block a specific percentage of UV, such as "99% to 100% UV absorbent."  is a better choice

Are darker sunglasses better?   Darker lenses don't mean better UV protection. Unless darker lenses are fabricated to block UV, they can be more harmful than wearing no sunglasses. That is because they cause pupils to dilate, allowing more UV light into the eyes. Lenses should be dark enough so that you can't see your eyes when looking in the mirror, but light enough to see curbs, stoplights and stairs.

How much should you pay?   It's possible to find great, protective sunglasses in the $20 to $60 range. More expensive sunglasses are not necessarily better, but super-cheap sunglasses (less than $20) are less likely to offer adequate protection.

healthyeyebuttonDry eyes, get relief with TheraLife Eye.
TheraLife is an all natural formula that restores your tear secretion glands to relief dry eyes with your own balanced sustainable tears all day long.

ChronicSevereDEbundleLearn more
Watch a video
Go to Store

Dr-Button2Call and talk to a doctor toll free 1-877-917-1989 US/Canada
email to info@theralife.com
Follow us on facebook and twitter

Tuesday, July 22, 2014

New Study Indicate Omega 3 May Help Wet Macular Degeneration



Macular degeneration creates vision problems especially when there is a macular hole- as depicted in the photo above where one cannot see the image at the center vision field.  This significantly impairs quality of life.

We macular degeneration is when the eye starts bleeding due to the fragile blood vessels in the eye, which can cause total blindness if left untreated.

A new study shows that omega-3 fatty acids could help with wet macular degeneration. Macular degeneration is expected to increase by fifty percent (50%) in older adults in industrialized countries by 2020. As the leading cause of vision loss in the elderly, it is a condition of serious significance. The macula is the central part of the retina.  It is responsible for the central vision. The retina is a thin layer of nerves and visual receptors at the back of the eye that is composed of rods and cones. It transmits visual signals to the brain. It is supported by the choroid, a network of blood vessels that feed and nourish the retina.

There are two forms of macular degeneration: wet and dry. In wet macular degeneration the main cause of vision loss is the growth of new blood vessels (neovascularization) in the choroid. These new blood vessels are fragile and leak blood, adding debris that clouds the retina and sometimes results in a retinal detachment. One potential treatment for wet macular degeneration is reducing neovascularization (new blood vessels) with a series of injections such as Lucentis, Avestin or Eylea. These are shots directly into the eye ball.

A new in vivo study shows that omega-3 fatty acids can radically reduce neovascularization in the choroid. The effect seems to be the result of metabolites of omega-3 fatty acids produced by the cytochrome P450 enzyme system. Mice fed omega-3′s had statistically significant lower rates of neovascularization. This offers promising hope for those suffering from wet macular degeneration, which comprises about 10% of all AMD cases.

Omega-3 fatty acids are found most plentifully in fish oil and krill oil, which is readily available in health food stores. There are vegetarian versions as well through algae sources.

Here are the references for this article.
Study: Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1401191111

Learn more about macular degeneration. Click here
healthyeyebutton

Anti-Aging, Preserve and Improve Vision

It is believed that macular degeneration is a caused at least in part by accumulation of unwanted proteins, lipids and debris in the eye.

TheraLife MaculaEye formula works to improve the integrity of the retina membrane by preserving and improving permeability to optimize fluid and protein transport.

This facilitates the transport of unwanted lipids, proteins out of the eye in order to improve and prevent vision loss.

Preserve Your Vision With MaculaEye

TheraLife MaculaEyeGo to Store
Dr-Button2Call and talk to a doctor toll free 1-877-917-1989 US/Canada
email to:  info@theralife.com
Follow us on facebook and twitter

Thursday, July 17, 2014

Elimination Diet to Relief Allergy Dry Eyes


Colorful fresh group of vegetables and fruits

Some of our customer who use TheraLife Eye has an allergy component to their dry eye syndrome.  Here is a story from one of our customers who used an elimination diet to further improve her dry eye relief while taking TheraLife Eye on daily basis. 

Here is her story

I have been taking TheraLife Eye for 4 years now.  I have allergies and my eyes are always itchy.  Recently, I tried and Elimination Diet which gave me further improvement.
This diet includes, No Gluten, No refined sugar, No dairy, and No caffeine. Also No GMO corn products. After two weeks on the diet, I had an appreciative change in my eye health - No redness, always moist and no itching senzation. This diet is not difficult to follow as one may think because  many restaurants provide great choices nowadays to allow you to stay on this diet, including Starbucks with no caffeine passion ice tea.   I continue to take TheraLife Eye for dry eye relief.  Adding this diet allowed me to be allergy free.
KA  Thousand Oaks, CA

healthyeyebuttonGet TheraLife Eye- restore normal tear function intra-cellularly.  Help produce your own natural balanced tears, long lasting comfort to relief dry eyes.

To learn more click here
ChronicSevereDEbundleWatch a video
Visit our store


Doctor-Rev1-bttnCall toll free and talk to a doctor 1-877-917-1989 from US/Canada
email us at info@theralife.com
follow us on facebook and twitter

Wednesday, July 2, 2014

Azithromycin- Preferred Treatment for Meibomian Gland Dysfunction.

New Research IndicatesAzithromycin is more effective than Doxycycline for Meibomian Gland Dysfunction and Blepharitis.
There are several studies concerning the use of topical azithromycin in ocular surface diseases. 
New research at the University of Louisville compared the effectiveness of topical azithromycin versus oral doxycycline therapy in meibomian gland dysfunction (and  Blepharitis) Twenty-two (22) subjects were treated with topical azithromucin solution for one month and seven subjects were treated with oral doxycycline for two (20 months. The study concluded that while both topical azithromycin and oral doxycycline improved clinical signs and symptoms of meibomian gland dysfunction, the "response to azithromycin is more rapid and more robust than doxycycline."
Another research study from the Ohio State University evaluated the efficacy of a four-week treatment with topical 1.0% azithromycin solution versus rewetting drops in patients with contact lens related dry eye.  Patients are able to wear contact lenses two-hours longer  throughout the four-week study period when azithromycin solution was use.
Blepharitis being a chronic inflammation of the eye lid goes hand in hand with Meibomian Gland Dysfunction and chronic dry eyes. Here is how TheraLife Eye can help!
How can TheraLife Eye Help?
TheraLife Eye is uniquely formulated to restore normal cell functions to tear secretion glands intra-cellularly for sustainable, long lasting relief. Clinically proven to work for 80% of first time users.  Antibiotics help reduce inflammation, however, inflammation shuts down tear secretion glands.  Use TheraLife Eye to restore normal tear function. 
 
Call us toll free 1-877-917-1989
International (650) 949-6080
Send inquiries to: info@theralife.com
Follow us at twitter and facebook

REFERENCES
1. Berman BM, Langevin HM, Witt CM, et al. Acupuncture for Chronic Low Back Pain. N Engl J Med 2010; 363:454-461.
2. Cassileth BR, Deng GE, Gomez JE, et al. Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed). Chest 2007;132(3 Suppl):340S-354S.
3. Li S, Yu B, Zhou D, et al. Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev 2011 Apr 13;4:CD007839.
4. Shaw KS, Bower KS, Mines MJ,et al. Does acupuncture treatment benefit dry eye? Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3839.
5. Hom MM. False staining appearance with lissamine green. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 1968.
6. Ocasio MA, Galor A, Zheng DD, et al. Trends in dry eye medication use and expenditures: Medical expenditure panel survey 2001 - 2006. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 5529.
7. Chi SL, Acquah K, Richard MJ, et al. Relation between punctual plug usage and reimbursement amongst medicare beneficiaries. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3852.
8. Mudgil P. Effect of hyperosmolarity on the antimicrobial properties of tear proteins. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 1486.
9. Foulks GN, Borchman D, Yappert MC. Comparative effectiveness of azithromycin and doxycycline in therapy of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3816.
10. Bickle KM, Nichols KK, Haque R, et al. Efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3842.
11. Senba K, Miyamoto T, Eguchi H, et al. The efficacy of oral pilocarpine for the treatment of dry eye symptoms in patients with aqueous tear deficiency and evaporative dry eye. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3837.
12. Miyamoto T, Eguchi H, Mitamura Y. An original administration of oral pilocarpine (Salagen tablet 5 mg) for dry eye. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 3835.
13. Labbe A, Brasnu E, Van Went C, et al. Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2011; 52 (6): E-abstract 218.
14. VanWent C, Alalwani H, Brasnu E, et al. Corneal sensitivity in patients treated for glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 201